Ekaterina Zakharova, MD, PhD
Valenta Pharm JSC
5
0
5
N/A
0
4
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Yuriy V. Lobzin, MD, PhD
Scientific Research Institute of Children's Infections, Federal Biomedical Agency, Saint-Petersburg, Russian Federation
Shared therapeutic areas:
Worked with same sponsors:
Matthew J Memoli, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Shared therapeutic areas:
Veryl Hodges, DO
Clopton Clinic
Shared therapeutic areas:
Shaukat A. Shah, MD
St. Joseph's Medical Associates, Stockton, CA 95204
Shared therapeutic areas:
Keith S. Reisinger, MD, MPH
Primary Physicians Research, Inc
Shared therapeutic areas:
Giuseppe D'Ignazio, MD
Source Unique Clinic
Shared therapeutic areas:
Lawrence P. Schwartz, MD
HCCA Clinical Research Solutions, New York, NY 10016
Shared therapeutic areas:
Terry L Poling, MD
Heartland Research Associates, LLC, Wichita, KS 67207
Shared therapeutic areas:
Michael Warren, MD
Research Across America at Oyster Point Family Health Center
Shared therapeutic areas:
Douglas W Mapel, MD
Clinical Trial Connection, Flagstaff, AZ 86001
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.
Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.
Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections
Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults
Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o.
All 5 trials loaded